EGR3 Polymorphism Is a Potential Susceptibility Factor of Schizophrenia Risk in a Chinese Population

Genet Test Mol Biomarkers. 2024 Apr;28(4):144-150. doi: 10.1089/gtmb.2023.0562.

Abstract

Objective: The purpose of this study was to evaluate the association between the single nucleotide polymorphisms (SNPs) (EGR3 rs1996147; EGR4 rs3813226, rs6747506; ERBB3 rs2292238; and ERBB4 rs707284, rs7560730) and the risk of schizophrenia (SZ) in a Chinese population. Materials and Methods: We conducted a case-control study, including 248 patients with SZ and 236 healthy controls matched for age and sex. The Mass-array platform was used to detect all the genotypes of the SNPs. Results: The results revealed that the EGR3 rs1996147 AA genotype was associated with borderline decreased SZ risk (AA vs. GG: adjusted OR = 0.43, 95% CI: 0.18-1.02, p = 0.06). However, no significant correlation was found between the other SNPs and overall SZ risk. Subgroup analysis also failed to show any significant association between all SNPs and the risk of SZ. Conclusion: In summary, this study revealed that the EGR3 rs1996147 AA genotype was associated with a borderline risk for SZ.

Keywords: genotypes; polymorphism; schizophrenia; single nucleotide polymorphisms.

MeSH terms

  • Adult
  • Alleles
  • Asian People* / genetics
  • Case-Control Studies
  • China / epidemiology
  • Early Growth Response Protein 3* / genetics
  • East Asian People
  • Female
  • Gene Frequency / genetics
  • Genetic Predisposition to Disease* / genetics
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide* / genetics
  • Receptor, ErbB-4 / genetics
  • Risk Factors
  • Schizophrenia* / genetics

Substances

  • Early Growth Response Protein 3
  • EGR3 protein, human
  • ERBB4 protein, human
  • Receptor, ErbB-4